19 results
8-K
EX-99.2
CRNX
Crinetics Pharmaceuticals, Inc.
12 Mar 24
Crinetics Announces Positive Topline Results from Phase 2 Trial of Paltusotine for the Treatment of Carcinoid Syndrome
4:25pm
Oncologists HCPs note the extensive training required for nurses to correctly prepare and administer injectable SRLs and would welcome an oral SRL
8-K
EX-99.1
dq192 29c04wt3
16 Jul 19
Crinetics Pharmaceuticals Appoints Stephanie Okey to Board of Directors
9:00am
DEF 14A
120mb5v9
29 Apr 19
Definitive proxy
12:00am
10-K
ihikbg zjz
13 Mar 19
Annual report
4:06pm
424B4
elqqes rfdfvuui67w
18 Jul 18
Prospectus supplement with pricing info
5:27pm
S-1/A
q4b0fhuqu36 oq
9 Jul 18
IPO registration (amended)
6:10am
S-1
svxyd pya1l0k
22 Jun 18
IPO registration
4:07pm
DRS/A
8kwbs 4ogpmek8vp7
11 Jun 18
Draft registration statement (amended)
12:00am
DRS
u1dvx
3 May 18
Draft registration statement
12:00am
- Prev
- 1
- Next